The Apamistamab Biosimilar Anti-CD45 Antibody is a cutting-edge product designed for research involving the CD45 protein, a critical cell surface molecule involved in immune regulation and cell signaling. This antibody, developed as a biosimilar to the widely-used anti-CD45 therapy, is highly specific and sensitive for detecting CD45 in various cell types.With its high reactivity in human samples, this antibody is ideal for use in Western blot applications, enabling researchers to accurately detect and analyze the CD45 protein. CD45 plays a crucial role in immune response modulation and has been implicated in a variety of diseases, making it a valuable target for studies in immunology and cancer research.
By utilizing the Apamistamab Biosimilar Anti-CD45 Antibody, researchers can gain valuable insights into the role of CD45 in immune homeostasis, inflammation, and diseases such as cancer and autoimmune disorders. This innovative antibody opens up new possibilities for developing targeted therapies that manipulate CD45 activity to modulate immune responses and potentially treat a range of health conditions.
Product Name:
Apamistamab (Anti-CD45) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0136
Target:
CD45
Host Species:
Mus musculus
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
Iomab-B
Description:
Anti-CD45 (apamistamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
